Skip Navigation LinksHome > August 2009 - Volume 31 - Issue 8 > Sustained Remission Achieved With ATRA and Chemotherapy in S...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3181979494
Original Articles

Sustained Remission Achieved With ATRA and Chemotherapy in Second Relapse of Acute Promyelocytic Leukemia in Down Syndrome

Ghosh, Indranil MD*; Kumar, Lalit DM*; Seth, Rachna DNB; Thavraj, Vasantha MD

Collapse Box


Children with Down syndrome (DS) are at an increased risk of developing acute leukemia. Acute myeloid leukemia predominates among DS children below 4 years of age but acute promyelocytic leukemia (APL) has rarely been reported in DS. Acute myeloid leukemia in DS is extremely sensitive to treatment but the optimum treatment of de novo or relapsed APL in DS is not known. We describe a child with DS and APL, who despite having a multiply relapsing course, achieved a third remission with ATRA and chemotherapy, which is sustained with maintenance therapy. A brief review of literature is also presented.

© 2009 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.